MedTech News
.................... by Andrew Celentano
New filters help genetic sequencing flag possible causes of meningitis and encephalitis
New research led by Aston University’s Dr. Ghaniah Hassan-Smith has found a new way to diagnose infections of the central nervous system, such as meningitis and encephalitis, that can be difficult to identify using conventional methods.
A simple pill could prevent sight loss in diabetes-driven eye condition, early findings suggest
Researchers at Trinity College Dublin, in collaboration with Breye Therapeutics, have found that an oral medication (“Danegaptide”) can protect against vision-threatening damage in nonproliferative diabetic retinopathy (NPDR), a leading cause of blindness in working-age adults.
Newly discovered inflammatory cell signaling could open the door to autoimmune disease treatments
Our understanding of how cells interact with each other has been driven for decades by the central concept of receptor-mediated signal transduction. Now, researchers from Boston Children’s Hospital are reporting the discovery of a new, receptor-free means of signal transduction.
Computer-designed T-cell receptors boost attacks on cancer and viral targets in early tests
A joint team of researchers at Bar-Ilan University and the Weizmann Institute has used advanced computational design methods to enhance the ability of genetically engineered immune cells to recognize and attack cancer and viral targets.
Experimental drug reverses paralysis and vision loss in multiple sclerosis model
A drug developed by a UVA Health scientist has not only stopped but reversed paralysis and vision loss in a mouse model of multiple sclerosis. The results are striking because existing MS treatments are designed to reduce future inflammatory attacks, not restore neurological function already lost.
PATHFINDER 2 findings advance multi-cancer early detection blood testing
A single blood draw that screens for more than 50 cancers substantially increased cancer detection when added to standard screening, identifying cancers that otherwise might have gone undetected until later stages, according to a new study from the Oregon Health & Science University Knight Cancer Institute.
Intuitive receives CE mark for transvaginal use of da Vinci SP system
The approval allows the da Vinci SP system to be utilised in more women’s health procedures across Europe.
First-in-human stroke trial reads blood clots from the inside
Scientists at the University of Galway have taken part in a first-in-human study of stroke patients using a thin wire fitted with sensors to assess and map their clots.